Drug intelligence / Profile preview

Dexven

Development stage
Unknown
Lead developer
Lyf Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Dexven is a branded generic antidepressant medication developed and marketed by Lyf Healthcare. Its active ingredient is desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI). The drug functions by blocking the reuptake of serotonin and norepinephrine through its interaction with the serotonin transporter (SERT) and norepinephrine transporter (NET), thereby increasing the synaptic concentrations of these neurotransmitters in the brain. Formulated as an oral tablet, Dexven is approved for the treatment of major depressive disorder (depression) and is available in strengths such as 50mg. Common side effects associated with its use include nausea, dizziness, insomnia, constipation, and potential increases in blood pressure.

Brand names
Dexven
Other names
desvenlafaxinedesvenlafaxine tablets
02

Targets

SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on Dexven.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dexven.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call